1
|
Brose K, Bland KS, Wang KH, Arnott D,
Henzel W, Goodman CS, Tessier-Lavigne M and Kidd T: Slit proteins
bind robo receptors and have an evolutionarily conserved role in
repulsive axon guidance. Cell. 96:795–806. 1999. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yuan W, Zhou L, Chen JH, Wu JY, Rao Y and
Ornitz DM: The mouse slit family: Secreted ligands for ROBO
expressed in patterns that suggest a role in morphogenesis and axon
guidance. Dev Biol. 212:290–306. 1999. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wu JY, Feng L, Park HT, Havlioglu N, Wen
L, Tang H, Bacon KB, Jiang ZH, Zhang XC and Rao Y: The neuronal
repellent slit inhibits leukocyte chemotaxis induced by chemotactic
factors. Nature. 410:948–952. 2001. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Ma WJ, Zhou Y, Lu D, Dong D, Tian XJ, Wen
JX and Zhang J: Reduced expression of slit2 in renal cell
carcinoma. Med Oncology. 31:7682014. View Article : Google Scholar
|
5
|
Smith-Berdan S, Schepers K, Ly A, Passegué
E and Forsberg EC: Dynamic expression of the robo ligand slit2 in
bone marrow cell populations. Cell cycle. 11:675–682. 2012.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Piper M, Georgas K, Yamada T and Little M:
Expression of the vertebrate slit gene family and their putative
receptors, the robo genes, in the developing murine kidney. Mech
Dev. 94:213–217. 2000. View Article : Google Scholar : PubMed/NCBI
|
7
|
Nones K, Waddell N, Song S, Patch AM,
Miller D, Johns A, Wu J, Kassahn KS, Wood D, Bailey P, et al:
Genome-wide DNA methylation patterns in pancreatic ductal
adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2
and MET signaling. Int J Cancer. 135:1110–1118. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Alvarez C, Tapia T, Cornejo V, Fernandez
W, Muñoz A, Camus M, Alvarez M, Devoto L and Carvallo P: Silencing
of tumor suppressor genes RASSF1A, SLIT2 and WIF1 by promoter
hypermethylation in hereditary breast cancer. Mol Carcinog.
52:475–487. 2013. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Qiu H, Zhu J, Yu J, Pu H and Dong R: SLIT2
is epigenetically silenced in ovarian cancers and suppresses growth
when activated. Asian Pac J Cancer Prev. 12:791–795.
2011.PubMed/NCBI
|
10
|
Wu W, Wong K, Chen J, Jiang Z, Dupuis S,
Wu JY and Rao Y: Directional guidance of neuronal migration in the
olfactory system by the protein slit. Nature. 400:331–336. 1999.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Hu H: Chemorepulsion of neuronal migration
by slit2 in the developing mammalian forebrain. Neuron. 23:703–711.
1999. View Article : Google Scholar : PubMed/NCBI
|
12
|
Liu D, Hou J, Hu X, Wang X, Xiao Y, Mou Y
and De Leon H: Neuronal chemorepellent slit2 inhibits vascular
smooth muscle cell migration by suppressing small GTPase Rac1
activation. Circ Res. 98:480–489. 2006. View Article : Google Scholar : PubMed/NCBI
|
13
|
Prasad A, Qamri Z, Wu J and Ganju RK:
Slit-2/robo-1 modulates the cxcl12/cxcr4-induced chemotaxis of t
cells. J Leukoc Biol. 82:465–476. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tole S, Mukovozov IM, Huang YW, Magalhaes
MA, Yan M, Crow MR, Liu GY, Sun CX, Durocher Y, Glogauer M and
Robinson LA: The axonal repellent, slit2, inhibits directional
migration of circulating neutrophils. J Leukoc Biol. 86:1403–1415.
2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Mukovozov I, Huang YW, Zhang Q, Liu GY,
Siu A, Sokolskyy Y, Patel S, Hyduk SJ, Kutryk MJ, Cybulsky MI and
Robinson LA: The neurorepellent slit2 inhibits postadhesion
stabilization of monocytes tethered to vascular endothelial cells.
J Immunol. 195:3334–3344. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Carmeliet P and Jain RK: Molecular
mechanisms and clinical applications of angiogenesis. Nature.
473:298–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Tie J and Desai J: Antiangiogenic
therapies targeting the vascular endothelia growth factor signaling
system. Crit Rev Oncog. 17:51–67. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Waldner MJ and Neurath MF: Targeting the
VEGF signaling pathway in cancer therapy. Expert Opin Ther Targets.
16:5–13. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lawson ND, Vogel AM and Weinstein BM:
Sonic hedgehog and vascular endothelial growth factor act upstream
of the notch pathway during arterial endothelial differentiation.
Dev Cell. 3:127–136. 2002. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zheng Y, Hao Z, Ding Y, Wang Q, Li S, Xiao
G, Luo H, Shi Q and Tong S: Expression of delta-like 4 (drosophila)
and vascular endothelial growth factor a in colon cancer and
association with tumour angiogenesis. J Int Med Res. 43:535–543.
2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Yoshida Y, Hayashi Y, Suda M, Tateno K,
Okada S, Moriya J, Yokoyama M, Nojima A, Yamashita M, Kobayashi Y,
et al: Notch signaling regulates the lifespan of vascular
endothelial cells via a p16-dependent pathway. PLoS One.
9:e1003592014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Chintala H, Krupska I, Yan L, Lau L, Grant
M and Chaqour B: The matricellular protein ccn1 controls retinal
angiogenesis by targeting VEGF, src homology 2 domain phosphatase-1
and notch signaling. Development. 142:2364–2374. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhang P, Yan X, Chen Y, Yang Z and Han H:
Notch signaling in blood vessels: From morphogenesis to
homeostasis. Sci China Life Sci. 57:774–780. 2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Qin F, Zhang H, Ma L, Liu X, Dai K, Li W,
Gu F, Fu L and Ma Y: Low expression of slit2 and robo1 is
associated with poor prognosis and brain-specific metastasis of
breast cancer patients. Sci Rep. 5:144302015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kramer SG, Kidd T, Simpson JH and Goodman
CS: Switching repulsion to attraction: Changing responses to slit
during transition in mesoderm migration. Science. 292:737–740.
2001. View Article : Google Scholar : PubMed/NCBI
|
26
|
Schmid BC, Rezniczek GA, Fabjani G, Yoneda
T, Leodolter S and Zeillinger R: The neuronal guidance cue slit2
induces targeted migration and may play a role in brain metastasis
of breast cancer cells. Breast Cancer Res Treat. 106:333–342. 2007.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Chang PH, Hwang-Verslues WW, Chang YC,
Chen CC, Hsiao M, Jeng YM, Chang KJ, Lee EY, Shew JY and Lee WH:
Activation of robo1 signaling of breast cancer cells by slit2 from
stromal fibroblast restrains tumorigenesis via blocking
pi3k/akt/β-catenin pathway. Cancer Res. 72:4652–4661. 2012.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Göhrig A, Detjen KM, Hilfenhaus G, Körner
JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B
and Fischer C: Axon guidance factor SLIT2 inhibits neural invasion
and metastasis in pancreatic cancer. Cancer Res. 74:1529–1540.
2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Kaur S, Castellone MD, Bedell VM, Konar M,
Gutkind JS and Ramchandran R: Robo4 signaling in endothelial cells
implies attraction guidance mechanisms. J Biol Chem.
281:11347–11356. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Kaur S, Samant GV, Pramanik K, Loscombe
PW, Pendrak ML, Roberts DD and Ramchandran R: Silencing of
directional migration in roundabout4 knockdown endothelial cells.
BMC Cell Biol. 9:612008. View Article : Google Scholar : PubMed/NCBI
|
31
|
Sheldon H, Andre M, Legg JA, Heal P,
Herbert JM, Sainson R, Sharma AS, Kitajewski JK, Heath VL and
Bicknell R: Active involvement of Robo1 and Robo4 in filopodia
formation and endothelial cell motility mediated via wasp and other
actin nucleation-promoting factors. FASEB J. 23:513–522. 2009.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Yang XM, Han HX, Sui F, Dai YM, Chen M and
Geng JG: Slit-Robo signaling mediates lymphangiogenesis and
promotes tumor lymphatic metastasis. Biochem Biophys Res Commun.
396:571–577. 2010. View Article : Google Scholar : PubMed/NCBI
|
33
|
Park KW, Morrison CM, Sorensen LK, Jones
CA, Rao Y, Chien CB, Wu JY, Urness LD and Li DY: Robo4 is a
vascular-specific receptor that inhibits endothelial migration. Dev
Biol. 261:251–267. 2003. View Article : Google Scholar : PubMed/NCBI
|
34
|
Jones CA, London NR, Chen H, Park KW,
Sauvaget D, Stockton RA, Wythe JD, Suh W, Larrieu-Lahargue F,
Mukouyama YS, et al: Robo4 stabilizes the vascular network by
inhibiting pathologic angiogenesis and endothelial
hyperpermeability. Nat Med. 14:448–453. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Jones CA, Nishiya N, London NR, Zhu W,
Sorensen LK, Chan AC, Lim CJ, Chen H, Zhang Q, Schultz PG, et al:
Slit2-Robo4 signalling promotes vascular stability by blocking arf6
activity. Nat Cell Biol. 11:1325–1331. 2009. View Article : Google Scholar : PubMed/NCBI
|
36
|
Han X and Zhang MC: Potential
anti-angiogenic role of slit2 in corneal neovascularization. Exp
Eye Res. 90:742–749. 2010. View Article : Google Scholar : PubMed/NCBI
|
37
|
Yu J, Zhang X, Kuzontkoski PM, Jiang S,
Zhu W, Li DY and Groopman JE: Slit2n and Robo4 regulate
lymphangiogenesis through the vegf-c/vegfr-3 pathway. Cell Commun
Signal. 12:252014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Youngblood V, Wang S, Song W, Walter D,
Hwang Y, Chen J and Brantley-Sieders DM: Elevated slit2 activity
impairs VEGF-induced angiogenesis and tumor neovascularization in
EphA2-Deficient Endothelium. Mol Cancer Res. 13:524–537. 2015.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Ho VC and Fong GH: Vasculogenesis and
angiogenesis in VEGF receptor-1 deficient mice. Methods Mol Biol.
1332:161–176. 2015. View Article : Google Scholar : PubMed/NCBI
|
40
|
Gale NW, Thurston G, Davis S, Wiegand SJ,
Holash J, Rudge JS and Yancopoulos GD: Complementary and
coordinated roles of the VEGFs and angiopoietins during normal and
pathologic vascular formation. Cold Spring Harb Symp Quant Biol.
67:267–273. 2002. View Article : Google Scholar : PubMed/NCBI
|
41
|
Hirashima M: Regulation of endothelial
cell differentiation and arterial specification by VEGF and notch
signaling. Anat Sci Int. 84:95–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
42
|
Krebs LT, Xue Y, Norton CR, Shutter JR,
Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J,
Callahan R, et al: Notch signaling is essential for vascular
morphogenesis in mice. Genes Dev. 14:1343–1352. 2000.PubMed/NCBI
|
43
|
Morimoto M, Liu Z, Cheng HT, Winters N,
Bader D and Kopan R: Canonical notch signaling in the developing
lung is required for determination of arterial smooth muscle cells
and selection of clara versus ciliated cell fate. J Cell Sci.
123:213–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Cao L, Arany PR, Wang YS and Mooney DJ:
Promoting angiogenesis via manipulation of VEGF responsiveness with
notch signaling. Biomaterials. 30:4085–4093. 2009. View Article : Google Scholar : PubMed/NCBI
|